Cargando…
Detecting clinically actionable variants in the 3′ exons of PMS2 via a reflex workflow based on equivalent hybrid capture of the gene and its pseudogene
BACKGROUND: Hereditary cancer screening (HCS) for germline variants in the 3′ exons of PMS2, a mismatch repair gene implicated in Lynch syndrome, is technically challenging due to homology with its pseudogene PMS2CL. Sequences of PMS2 and PMS2CL are so similar that next-generation sequencing (NGS) o...
Autores principales: | Gould, Genevieve M, Grauman, Peter V, Theilmann, Mark R, Spurka, Lindsay, Wang, Irving E, Melroy, Laura M, Chin, Robert G, Hite, Dustin H, Chu, Clement S, Maguire, Jared R, Hogan, Gregory J, Muzzey, Dale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162901/ https://www.ncbi.nlm.nih.gov/pubmed/30268105 http://dx.doi.org/10.1186/s12881-018-0691-9 |
Ejemplares similares
-
Correction: Sequencing as a first-line methodology for cystic fibrosis carrier screening
por: Beauchamp, Kyle A., et al.
Publicado: (2019) -
Sequencing as a first-line methodology for cystic fibrosis
carrier screening
por: Beauchamp, Kyle A., et al.
Publicado: (2019) -
GAPDH Pseudogenes and the Quantification of Feline Genomic DNA Equivalents
por: Helfer-Hungerbuehler, A. Katrin, et al.
Publicado: (2013) -
A Pathogenic Variant Reclassified to the Pseudogene PMS2P1 in a Patient with Suspected Hereditary Cancer
por: Fragoso-Ontiveros, Veronica, et al.
Publicado: (2023) -
Development and validation of a 36-gene sequencing assay for hereditary cancer risk assessment
por: Vysotskaia, Valentina S., et al.
Publicado: (2017)